Amphiregulin-dependant deacetylation of Ku70 promotes BAX inhibition and resistance to gefitinib in non small cell lung cancer

被引：0
|
作者：
Busser, B. [1 ]
Niang, C. [1 ]
Coll, J. L. [1 ]
Favrot, M. [1 ]
Hurbin, A. [1 ]
机构：
[1] CHU Grenoble, Inst Albert Bonniot, INSERM, Dept Biol Integree Cancerol,U578, Grenoble, France
来源：
BULLETIN DU CANCER | 2008年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S77 / S77
页数：1
相关论文
共 50 条
  • [31] Overexpression of Cathepsin L is associated with gefitinib resistance in non-small cell lung cancer
    Cui, F.
    Wang, W.
    Wu, D.
    He, X.
    Wu, J.
    Wang, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (07): : 722 - 727
  • [32] Erlotinib/gefitinib/osimertinibDevelopment of resistance in non-small cell lung cancer: case report
    Reactions Weekly, 2021, 1850 (1) : 131 - 131
  • [33] Src mediates ERK reactivation in gefitinib resistance in non-small cell lung cancer
    Ochi, Nobuaki
    Takigawa, Nagio
    Harada, Daijiro
    Yasugi, Masayuki
    Ichihara, Eiki
    Hotta, Katsuyuki
    Tabata, Masahiro
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    EXPERIMENTAL CELL RESEARCH, 2014, 322 (01) : 168 - 177
  • [34] Losmapimod Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer by Preventing Tetraploidization
    Yeung, Yiu To
    Yin, Shuying
    Lu, Bingbing
    Fan, Suyu
    Yang, Ran
    Bai, Ruihua
    Zhang, Chengjuan
    Bode, Ann M.
    Liu, Kangdong
    Dong, Zigang
    EBIOMEDICINE, 2018, 28 : 51 - 61
  • [35] Effects of BTK inhibitor on gefitinib-resistance non-small cell lung cancer
    Hong, T-M.
    Fang, Y-T.
    Chen, Y-L.
    ANNALS OF ONCOLOGY, 2017, 28
  • [36] Overexpression of Cathepsin L is associated with gefitinib resistance in non-small cell lung cancer
    F. Cui
    W. Wang
    D. Wu
    X. He
    J. Wu
    M. Wang
    Clinical and Translational Oncology, 2016, 18 : 722 - 727
  • [37] EGFR mutation conferring primary resistance to gefitinib in non-small-cell lung cancer
    Shih, JY
    Gow, CH
    Yang, PC
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02): : 207 - 208
  • [38] β-Catenin overexpression is associated with gefitinib resistance in non-small cell lung cancer cells
    Fang, Xia
    Gu, Pan
    Zhou, Caicun
    Liang, Aibin
    Ren, Shenxiang
    Liu, Fang
    Zeng, Yu
    Wu, Yunjin
    Zhao, Yinmin
    Huang, Binbin
    Zhang, Zongmei
    Yi, Xianghua
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2014, 28 (01) : 41 - 48
  • [39] Gefitinib/osimertinibAcquired resistance in advanced non-small cell lung cancer: case report
    Reactions Weekly, 2021, 1863 (1) : 165 - 165
  • [40] FTO promotes gefitinib-resistance by enhancing PELI3 expression and autophagy in non-small cell lung cancer
    He, Yu-Zheng
    Li, Xiao-Ning
    Li, Hai-Tao
    Bai, Xian-Hua
    Liu, Yan-Chao
    Li, Fan-Nian
    Lv, Bao-Lei
    Qi, Tian-Jie
    Zhao, Xiu-Min
    Li, Shuai
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2024, 87
12345